Pfizer Picks Catalent to Manufacture Newly Launched Pain-Relief Product
Pfizer’s new format of ibuprofen (AdvilR Liqui-GelsR Minis) uses Catalent’s softgel technology to deliver the formulation in a more concentrated fill, resulting in smaller capsules.
Catalent Pharma Solutions, provider of advanced drug-delivery technologies, announced that it has entered into an exclusive long-term supply agreement to produce Pfizer’s newly launched over-the-counter (OTC) pain relief product-Advil Liqui-Gels Minis (ibuprofen)-which uses Catalent’s softgel platform OptiGel Mini technology.
Catalent has collaborated with Pfizer for 20 years on the development and manufacture of Advil Liqui-Gels. The new format, Advil Liqui-Gels Minis, delivers the formulation in a more concentrated fill, resulting in smaller capsules that are easier to swallow. Smaller capsules address the problem of swallowing difficulties often experienced by pediatric and geriatric consumers.
Under the arrangement, Catalent’s St. Petersburg, Florida, facility has already formulated and is manufacturing the new format for Pfizer. The new product was recently launched in the US market.
Source: Catalent
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
PostEra Expands Pfizer Partnership with AI Lab and ADC Collaborations
January 8th 2025The AI Lab was launched almost exactly three years ago and has produced several programs so far, at least one of which achieved its first scientific stage gate 40% faster than the teams originally forecasted.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
